Overview

  • Product nameAsenapine maleate
  • Description
    Multiple receptor antagonist. Antipsychotic agent.
  • Alternative names
    • ASE
  • Biological descriptionNovel, multiple receptor antagonist. Displays activity at 5-HT, dopamine, adrenoceptors and histamine receptors. (pKi values are 8.60 (5-HT1A), 8.40 (5-HT1B), 10.15 (5-HT2A), 9.75 (5-HT2B), 10.46 (5-HT2C), 8.84 (5-HT5A), 9.60 (5-HT6), 9.94 (5-HT7), 8.85 (D1), 8.90 (D2L), 8.84 (D2S), 9.38 (D3), 8.95 (D4), 8.93 (α1A), 8.9 (α2A), 9.49 (α2B), 8.91 (α2C), 9.00 (H1) and 8.21(H2)). Increases dopamine, norepinephrine and acetylcholine efflux. Antipsychotic in vivo.
  • Purity> 99%

Properties

    References for Asenapine maleate (ab120576)

    This product has been referenced in:
    • Shahid M  et al. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol 23:65-73 (2009). Read more (PubMed: 18308814) »
    • Marston HM  et al. Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology (Berl) 206:699-714 (2009). Read more (PubMed: 19462162) »
    • Huang M  et al. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus. Neuropsychopharmacology 33:2934-45 (2008). Read more (PubMed: 18418367) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120576.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"